Award
Delivery Order #SPE2DR26FA7F9
Delivery Order for Engerix-B Vaccine under AmerisourceBergen's Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$2,761.54
Ceiling
$2,761.54
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2DR26FA7F9
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, under an existing Indefinite Delivery Vehicle (IDV) contract. The contract involves procuring the Engerix-B vaccine formulation (20 mcg/ml), highlighting AmerisourceBergen's role in ensuring the availability of critical pharmaceutical products. The specific scope covers the delivery of this vaccine at a designated location in Pennsylvania within a very short timeframe, indicating an urgent or routine replenishment. As a delivery order under a long-term federal supply schedule contract, this agreement supports federal healthcare procurement by guaranteeing access to essential immunizations. The contract was awarded as part of the ongoing indefinite delivery contract, which is not sole-source but detailed competitive procurement information is unavailable. The delivery order is scheduled for a single-day performance, emphasizing a precise and swift supply operation.
Description
4570970751!ENGERIX-B 20 MCG/ML SYRNML